Clinical Trial Update: Safety and Efficacy Trial of TV5M01 for Radiation-Induced Mucositis in Head and Neck Cancer Patients. [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describing a Phase 1/2 study of TV5M01 for radiation-induced mucositis in head and neck cancer patients, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucositis
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• TV5M01

Snippet

Sponsor: Fundacion Clinica Valle del Lili | Conditions: Squamous Cell Carcinoma of the Head and Neck, Oral Mucositis | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING